tiprankstipranks
Trending News
More News >
CStone Pharmaceuticals (HK:2616)
:2616
Hong Kong Market

Compare CStone Pharmaceuticals (2616) vs. Competitors

Compare
4 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
CStone Pharmaceuticals
HK$5.34
HK$8.41B
-18.80
171.30%
1 Buy
0 Hold
0 Sell
Moderate Buy
Alphamab Oncology
HK$9.58
HK$10.65B
41.25
230.89%
2 Buy
0 Hold
0 Sell
Moderate Buy
HBM Holdings Ltd.
HK$12.08
HK$12.36B
19.21
489.21%
1 Buy
0 Hold
0 Sell
Moderate Buy
Jiangsu Recbio Technology Co., Ltd. Class H
HK$4.18
HK$1.90B
-2.82
-49.70%
Abbisko Cayman Limited
HK$13.02
HK$9.79B
51.73
229.09%
4 Buy
0 Hold
0 Sell
Strong Buy
Shandong Boan Biotechnology Company., Limited. Class H
HK$9.48
HK$5.90B
151.94
13.13%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:2616
CStone Pharmaceuticals
5.86
3.72
173.83%
HK:9966
Alphamab Oncology
10.82
7.44
220.12%
HK:2142
HBM Holdings Ltd.
14.20
11.55
435.85%
HK:2179
Jiangsu Recbio Technology Co., Ltd. Class H
4.16
-4.11
-49.70%
HK:2256
Abbisko Cayman Limited
14.48
10.06
227.60%
HK:6955
Shandong Boan Biotechnology Company., Limited. Class H
9.39
0.63
7.19%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts